Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 86, Issue 7, Pages 533-539
Publisher
Wiley
Online
2011-03-25
DOI
10.1002/ajh.22037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Cell and Matrix Accumulation During Atherogenesis in Mice With Vessel Wall–Specific Deletion of Discoidin Domain Receptor 1
- (2010) Christopher Franco et al. CIRCULATION RESEARCH
- Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a ‘head-to-head comparison’
- (2010) Gianantonio Rosti et al. LEUKEMIA & LYMPHOMA
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended kinase profile and properties of the protein kinase inhibitor nilotinib
- (2009) Paul W. Manley et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
- (2009) G. Rosti et al. BLOOD
- Discoidin Domain Receptor 1 on Bone Marrow–Derived Cells Promotes Macrophage Accumulation During Atherogenesis
- (2009) Christopher Franco et al. CIRCULATION RESEARCH
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
- (2009) Michele Baccarani et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of BaselineBCR-ABLMutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase
- (2009) Timothy Hughes et al. JOURNAL OF CLINICAL ONCOLOGY
- New Directions in the Treatment of Imatinib Failure and/or Resistance
- (2009) Francis J. Giles SEMINARS IN HEMATOLOGY
- Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
- (2008) S. Branford et al. BLOOD
- Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease
- (2008) Peter Valent BRITISH JOURNAL OF HAEMATOLOGY
- Discoidin Domain Receptor 1 ( Ddr1 ) Deletion Decreases Atherosclerosis by Accelerating Matrix Accumulation and Reducing Inflammation in Low-Density Lipoprotein Receptor–Deficient Mice
- (2008) Christopher Franco et al. CIRCULATION RESEARCH
- Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
- (2008) Elizabeth Day et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nilotinib: a phenylamino-pyrimidine derivative with activity against BCR-ABL, KIT and PDGFR kinases
- (2008) Alfonso Quintás-Cardama et al. Future Oncology
- New therapeutic approaches and prognostic factors in chronic myeloid leukemia
- (2008) Giuseppe Saglio et al. LEUKEMIA & LYMPHOMA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now